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Purpose: Wegener’s granulomatosis (WG) is a rare
multisystem inflammatory disease, which infrequently involves
the subglottic area and trachea. Treatment usually involves the
use of immunosuppressive agents with corticosteroids. Some
patients, however, continue to have symptoms of airway
obstruction after clinical remission following the standard
therapeutic regimen. Objective: To investigate laser treatment
for subglottic stenosis in five patients suffering from WG.
Materials and Methods: We endoscopically treated 5 patients
with subglottic stenosis due to WG and airway obstruction by
Nd:YAG and CO2 lasers. One of the patients had preoperative
tracheostomy and after treatment was decannulated and could
not breathe without dyspnea. Another patient required stenting
of the subglottic area. Results: All five patients were able to
breathe without dyspnea after the treatment. Three patients
were treated with an Nd:YAG laser but needed repeated laser
treatment every four to six months, whenever they complained
of dyspnea. The other two patients were treated with a CO2
laser; one of these patients had preoperative tracheostomy and
was treated twice by CO2 laser and decannulated, with no
further difficulty in breathing. The follow-up period was 1-5
years. Conclusions: Nd:YAG and CO2 lasers are recommended
in the treatment of subglottic stenosis (SS) due to WG,
particularly when the stenosis is in continuity or close
proximity to the vocal cords.
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INTRODUCTION
Wegener’s granulomatosis (WG) is a rare multi-
system inflammatory disease of unknown origin,
characterized by necrotizing granulomatous in-
flammation and necrotizing vasculitis of the upper
and lower respiratory tract, glomerulonephritis
and a variable degree of small vessel vasculitis.
Nasal and oral ulceration, epistaxis, sinusitis, or
otitis is found in more than 90% of the cases.
1
Ulcers in the larynx and trachea were seen in
about a quarter of the cases of WG.
2,3 Subglottic
stenosis (SS) is considered to be less common.
3,4
This rare form of the disease (SS due to WG) often
responds to medical treatment of cyclophospha-
mide with or without corticosteroids,
5,6 but when
patients continue to complain of respiratory dif-
ficulty due to SS, surgical treatment is necessary.
7,8
There are a wide variety of possible surgical
interventions including dilatation, stents, or major
open operations, such as laryngofissure with or
without skin or mucosal grafts and segmental
resection of the stenotic area.
6,9,10
Research has concentrated on the use of a CO2
laser for the treatment of SS.
2,11-13
In this study we report on a series of five
patients with subglottic stenosis related to WG,
who were treated by endoscopic laser surgery:
three with an Nd : YAG laser and two with a CO2
laser. We also review the literature concerning
tracheal reconstruction options for cases of SS due
to WG.
MATERIALS AND METHODS
Patients
We treated 5 patients (4 female, 1 male) with SS
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due to WG by laser. The patients' ages ranged
between 21 and 83 years, with a mean age of 35.8
years. All patients were positive for complement
antineutrophil cytoplasm antibody (c-ANCA)
according to blood tests.
The patients were evaluated by CT scan, chest
x-ray, and pulmonary function studies. Preopera-
tive fiber optic laryngoscopy and bronchoscopy
provided valuable information regarding vocal
cord mobility, the extent of the stenosis, and the
distance from the vocal cords.
The stenoses were firm, with a granulomatous
rim, and extended below the vocal cord 0.5 to 1.5
cm, with an average thickness of 1.7 cm. Com-
puter tomography showed circumferential steno-
sis causing narrowing of the lumen in the
subglottic area in three patients. One patient had
a preoperative tracheostomy (Table 1).
All patients were treated by the immuno-
suppressive agent, cyclophosphamide, with corti-
costeroids, but they continued to suffer from
dyspnea on exertion and stridor. Pulmonary
function testing revealed a flattening of the flow-
volume loop with inspiration, consistent with an
extra-thoracic airway obstruction (Fig. 1).
Surgical procedure
Direct microlaryngoscopy was performed under
general anesthesia in two patients (one required
an endotracheal tube and one was anesthetized
via a prior tracheostomy). A Storz laser laryngo-
scope was used to expose the glottic and the sub-
glottic areas. A Zeiss microscope with a 400-mm
objective lens coupled to a CO2 laser was used in
both cases. The laser setting was 10 W in a con-
tinuous mode. Moistened neurosurgical pledgets
were placed in the subglottic space to protect the
trachea and endotracheal tube during excision of
the stenotic area in order to reduce the lateral
thermal damage of the CO2 laser.
Three patients underwent bronchoscopy under
local anesthesia and an Nd:YAG laser was used
with Olympus fiber-optic bronchoscopy.
The laser energies ranged from 2500 to 6000
Joules, applied in a 50 W continuous mode. In one
patient, we placed a 12/30 mm wall stent. The
Table 1. Clinical Data of Five Patients with Subglottic Stenosis
No.
Age
(yrs)
Sex
(M/F)
Nose/Sinus
Tracheostomy Stenosis
Preop. Postop. Thickness/cm Diameter/mm Distance/cm*
1 29 F Saddle nose Chronic
sinusitis
Yes No 1 Total 1
2 20 M Saddle nose Septal
perforation
No No 2 5, circular 1.5
3 25 F Saddle nose No No 3 4, circular 1
4 83 F - No No 1 6, anterior 0.5
5 25 F - No No 1.5 6, anterior 0.5
*Distance of the stenosis from the vocal cord (cm).
Fig. 1. Preoperative pulmonary function testing.Jacob Shvero, et al.
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preoperative SS is shown in Fig. 2. Both the CO2
and Nd: YAG laser procedures took no longer
than 20 minutes.
RESULTS
We treated two patients by CO2 laser because
the SS was in close proximity to the vocal cords
(within 0.5 - 1 cm). One patient, who had under-
gone a preoperative tracheostomy, also under-
went two interventions with dilatation and the
other patient underwent four additional inter-
ventions. These patients were in the hospital for
only 24 hours after CO2 laser treatment.
The other three patients were treated by an Nd
: YAG laser and underwent 5 - 18 interventions
(the SS was between 1 - 1.5 cm below the vocal
cords), and these patients were discharged one
hour after the procedure. None of the five patients
needed emergency tracheostomy. The follow-up
period for all of our patients ranged from 1 to 5
years (Table 2).
The resolution of dyspnea on exertion or
decannulation was the criteria for success.
Four patients had no dyspnea during the fol-
low-up period. The fifth patient needed repeated
intervention after two and three months because
of episodes of dyspnea on exertion, and this
patient ultimately required an SS stent. The SS in
this patient had an opening diameter of 4 mm.
The stenotic segment was short and had soft
Table 2. Laser Treatment and Follow-up
No. CO2 laser Nd : YAG laser Interventions (n) Outcome Follow-up/months
1 Yes + dilatation - 2 Decannulated 12
2 - Yes 10 Favorable 60
3 - Yes 18 Favorable 6
4 - Yes 5 Favorable 24
5 Yes - 4* Favorable 6
*stent.
Fig. 2. Tracheoscopic image of preoperative subglottic
stenosis.
Fig. 3. Postoperative pulmonary function testing.Laser Surgery in Subglottic Stenosis & Wegener Disease
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tissue. Another patient who had preoperative
tracheostomy was decannulated after two inter-
ventions by CO2 laser.
There was no voice disturbance after treatment
in our patients. Postoperative pulmonary function
testing showed an improvement (Fig. 3). Fig. 4
shows the postoperative results after laser treat-
ment.
Histological examination
All specimens were fixed in 10% buffered
formalin, embedded in paraffin, and stained with
haematoxylin and eosin. The biopsies demons-
trated focal acute necrosis surrounded by a zone
of fibroblastic proliferation with giant cells and
leukocytic infiltrate. The vasculitis affected small
arteries and veins. These granulomatous inflam-
matory changes were consistent with the dia-
gnosis of WG.
DISCUSSION
SS occurs in nearly 16 to 23% of patients with
WG.
1,4,14 Significant SS is defined as the presence
of symptomatic airway compromise, usually con-
sisting of dyspnea, voice changes, or cough. For
unknown reasons, SS is more common in young
patients. The clinical course of SS generally runs
independently of systemic WG activity.
14 Patients
with WG are at great risk for severe airway
obstruction, which can rapidly run a fatal course
if not treated.
15 In the absence of other features of
acute WG, isolated SS is optimally managed with
intratracheal laser treatment and does not require
systemic therapy; this is the best approach in
cases, such as our patients, where SS is in close
proximity to or in continuity with the vocal cords.
A CO2 laser emits an invisible beam of light at
10.6 m, which is selectively absorbed by water. μ
The CO2 laser has distinct advantages over con-
ventional steel knives. It seals blood vessels less
than 0.5 mm in diameter, resulting in superior
haemostasis, and it can be used in ablation mode
for vaporizing tissue and for incisions. Therefore,
this method is frequently used for micro-laryngeal
surgery. However, a major disadvantage of the
CO2 laser is that fiber-optic transmission is not
possible. The ultra spot micromanipulator deli-
very system allows a spot size of 200 m, at a μ
400-mm focal distance.
The Nd:YAG laser, which is an excellent photo
coagulator and can be transmitted through fiber-
optic cables, emits a beam of light at 1.06 m. The μ
ND:YAG laser utilizes a 220-V energizer and
needs an exterior cooling device, is less precise,
having a 20 to 40% scatter, and its beam of light
penetrates deeply and is absorbed by water. The
Nd: YAG laser can also cause edema and scarring.
Because of its excellent ability to evaporate and
coagulate, it is used as surgical intervention for
obstructive lesions in the tracheobronchial area.
6
In 1984, Dedo et al.
2 described a new technique
for the treatment of posterior glottic, subglottic,
and tracheal stenosis with a CO2 laser and
microtrapdoor mucosal flap. Nine of the ten
patients in their study were given an adequate
airway and good voice. In 1979, Strong et al.
13
presented a study involving 18 patients with
glottic or subglottic partial or total stenosis. Using
a laser, they successfully treated 4/7 and 8/11 SS
cases. Six of the latter also had temporary
placement of Silastic roll stents. Lebovics et al.
12
described 8 out of 25 cases of CO2 laser Treatment,
and they reported that subglottic scarring
recurred rapidly and was more extensive after
each laser procedure. All 8 of their patients
Fig. 4. Tracheoscopic image of postoperative subglottic
stenosis.Jacob Shvero, et al.
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ultimately required other therapies to adequately
manage the stenosis.
In 2003, Gluth et al.
14 described their experience
in repairing SS in WG and recommended mini-
mizing the airway manipulation during episodes
of systemic disease activity. Once the disease
process is under control, consideration can then
be given to either an endoscopic or an open
approach based on the extent of stenosis. Either
laryngotracheal reconstruction or CO2 laser
resection and dilation can be safely used to
produce a favorable outcome.
Alternative approaches that minimize the
frequency of episodes of recurrent disease, such as
trimethoprim-sulfamethoxazole therapy, are
currently under investigation.
14,16
SS at the level of the cricoids cartilage and/or
upper tracheal rings present a management
dilemma
12 as the stenosis is in close proximity to
the vocal cords. In these cases, laser treatment
should be used to preserve the quality of the voice
as any other open surgery might damage the
vocal cords. In patients, especially young patients,
with SS in close proximity or in continuity with
the vocal cords, if the patient complains of
dyspnea, repeated laser intervention is preferred
over permanent tracheostomy or laryngotracheal
resection.
Our patients were diagnosed with WG by a
positive c-ANCA blood test and by histological
examination. For treatment, we used CO2 laser for
two patients with SS close to the vocal cords (0.5-1
cm) since the Nd : YAG laser can penetrate
deeply, causing edema and scarring that would
affect the quality of the voice. The Nd : YAG laser
was used in the other three patients with SS
located far from the vocal cords (1 - 1.5 cm). The
Nd:Yag laser is preferred over the CO2 laser when
the SS is near the upper trachea and because it can
be done under local anesthesia and allows for
multiple interventions.
As a result of our study, we recommend laser
treatment for treatment of SS for the following
reasons: it requires a short surgical intervention
(no longer than 20 minutes) and short hospi-
talization; there is no bleeding and no scarification
of the recurrent nerve; laser treatment can be done
without tracheostomy; it does not produce cos-
metic defects in the neck skin; it is suitable for
high risk patients; it can be performed if the SS
is in close proximity or in continuity with the
vocal cords; and it produces favorable results. In
cases where endoscopic treatment by laser has
failed, we suggest performing laryngotracheal
resection with reconstruction.
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